Nilotinib With Chemotherapy for the Treatment of Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

NCT00905398 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
8
Enrollment
OTHER
Sponsor class

Stopped The study was terminated due to excessive toxicity and low compliance to the protocol scheme.

Conditions

Interventions

Sponsor

Rony Schaffel